We are live on ! Find out more
OPRX icon

OptimizeRx

53 hedge funds and large institutions have $110M invested in OptimizeRx in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

100% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 11

52% more capital invested

Capital invested by funds: $72.4M → $110M (+$37.8M)

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

11% more call options, than puts

Call options by funds: $625K | Put options by funds: $563K

4% more funds holding

Funds holding: 5153 (+2)

3.15% more ownership

Funds ownership: 54.62%57.76% (+3.1%)

Holders
53
Holders Change
+2
Holders Change %
+3.92%
% of All Funds
1.09%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
11
Increased
22
Reduced
11
Closed
8
Calls
$625K
Puts
$563K
Net Calls
+$62K
Net Calls Change
+$1.56M

OPRX Hedge Fund Activity: Q2 2020 in Review

53 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q2 2020, worth a combined $110M — up 52% from $72.4M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new OPRX positions and 8 closed out — a net gain of 3 holders — while 22 added to existing stakes and 11 trimmed.

The largest buyer was First Light Asset Management, opening a new position worth an estimated $6.41M. The largest seller was Park West Asset Management, exiting entirely with an estimated $6.17M sold.

  • 53 institutional investors held OptimizeRx (OPRX) as of Q2 2020, up from 51 in Q1 2020.
  • Funds reported $110M of OptimizeRx stock for Q2 2020, up 52% quarter-over-quarter.
  • 11 funds opened new OptimizeRx positions in Q2 2020 and 8 closed out, a net change of +3 holders.
  • The largest OptimizeRx buyer in Q2 2020 was First Light Asset Management, an estimated $6.41M added.
  • The largest OptimizeRx seller in Q2 2020 was Park West Asset Management, an estimated $6.17M sold.

Based on aggregated 13F filings for Q2 2020.